Alex­ion’s new CEO is bring­ing an old col­league in to run R&D, can new deals be far be­hind?

Af­ter an­nounc­ing a clean sweep of the ex­ec­u­tive suite a few days ago, Alex­ion’s new CEO Lud­wig Hantson is bring­ing in a very fa­mil­iar face to take over as head of R&D.

Hantson chose John Orloff, his R&D chief at the short-lived Bax­al­ta, to take over the helm at Alex­ion’s re­search group, re­plac­ing Mar­tin Mack­ay. The move like­ly sig­nals some loom­ing pipeline changes at the com­pa­ny, which sells Soliris, one of the world’s most ex­pen­sive ther­a­peu­tics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER